Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study

FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CSTL–Castle shared new data demonstrating how the independent risk-stratification of DecisionDx®-SCC can significantly improve metastatic risk predictions.
Click here to view original post